35250-76-1

Basic information

• Product Name: 5-PROPYL-THIOPHENE-2-CARBALDEHYDE
• Synonyms: TIMTEC-BB SBB010356;AKOS B030362;5-PROPYL-THIOPHENE-2-CARBALDEHYDE;ART-CHEM-BB B030362;VITAS-BB TBB010453
• CAS NO: 35250-76-1
• Molecular Formula: C₈H₁₀OS
• Molecular Weight: 154.23
• Mol File: 35250-76-1.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 244.6 °C at 760 mmHg
• Flash Point: 95.3 °C
• Appearance: /
• Density: 1.102 g/cm³
• CAS DataBase Reference: 5-PROPYL-THIOPHENE-2-CARBALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-PROPYL-THIOPHENE-2-CARBALDEHYDE(35250-76-1)
• EPA Substance Registry System: 5-PROPYL-THIOPHENE-2-CARBALDEHYDE(35250-76-1)

Safety Data

• Hazard Codes: Xi
• Statements: 43
• Safety Statements: 36/37
• HazardClass: IRRITANT
• Hazardous Substances Data: 35250-76-1(Hazardous Substances Data)

Upstream product

• 1551-27-5 2-propylthiophene 
• 93-61-8 N-methyl-N-phenylformamide 
• 57-13-6 urea 
• 20524-86-1 dichloromethyl ether 
• 13679-75-9 1-thiophen-2-yl-propan-1-one 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 112687-98-6 bis-(4-dimethylamino-phenyl)-(5-propyl-[2]thienyl)-methane 
• 33933-73-2 2-methyl-5-propyl-thiophene 
• 63068-73-5 5-n-propylthiophene-2-carboxylic acid 
• 1429192-07-3 C₂₁H₂₀N₂OS 
• 603-35-0 triphenylphosphine 

Relevant articles and documents

DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF

The present invention relates to a diarylo[a,g]quinolizidine compound of formula (I), enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate or solvate thereof; the preparation method thereof, and uses thereof in preparing an experimental model drugs related to dopamine receptors and 5-HT receptors or a medicament for treating or preventing a disease related to dopamine receptors and 5-HT receptors.

THIOPHENE- SUB STITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

Disclosed are novel Thiophene-Subsituted Tetracyclic Compounds of Formula (I). And pharmaceutically acceptable salts thereof, wherein A, A', R2, R3, R4 and R5 are as defined herein. The compositions comprising at least one Thiophene-Subsituted Tetracyclic Compounds, and methods of using the Thiophene-Subsituted Tetracyclic Compounds for treating or preventing HCV infection in a patient are also disclosed.

ANTIBACTERIAL AGENTS: ARYL MYXOPYRONIN DERIVATIVES

The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.